281%
The stock of a little-known biotech company, Intercept Pharmaceuticals Inc., went up 281% on Thursday after the company’s liver-disease drug performed well in a clinical trial, marking the biggest one-day stock leap among Nasdaq Composite companies of a similar size since at least 2012.
(Source: Wall Street Journal)
